GlassScriptPhysician profile
Jonathan M Kurss
NPI 1154685121
$2,166.90
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $525 · 2021: $527 · 2022: $423 · 2024: $11.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $429.25 | 2019-2022 | |
| Therapeuticsmd, INC. | $386.53 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $196.69 | 2019-2022 | |
| Caldera Medical, INC | $150.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.76 | 2019-2020 | |
| Myovant Sciences INC. | $107.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $97.12 | 2019-2021 | |
| Pfizer INC. | $81.27 | 2019-2022 | |
| Evofem Biosciences, INC. | $61.16 | 2021-2022 | |
| Ethicon US, LLC | $59.41 | 2020-2022 | |
| Lupin INC. | $48.67 | 2020 | |
| Organon LLC | $45.20 | 2022-2024 | |
| Coopersurgical, INC. | $42.96 | 2019-2020 | |
| Sage Therapeutics, LLC | $40.84 | 2019-2021 | |
| Boston Scientific Corporation | $36.30 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $32.59 | 2019 | |
| Mayne Pharma Commercial LLC | $27.67 | 2021 | |
| Hologic Sales and Service, LLC | $24.41 | 2019 | |
| Avanos Medical | $24.19 | 2022 | |
| Sagent Pharmaceuticals | $24.02 | 2022 | |
| Astellas Pharma US INC | $23.11 | 2019 | |
| Laborie Medical Technologies Corp. | $20.91 | 2020 | |
| Daiichi Sankyo INC. | $20.62 | 2019 | |
| Aspira Women'S Health INC | $20.30 | 2022 | |
| Agile Therapeutics, INC. | $18.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Kurss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.